Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	Eye irritation	Eye disorders	Placebo	3	94
other	Eye irritation	Eye disorders	Low Concentration	7	96
other	Eye irritation	Eye disorders	High Concentration	13	96
other	Eye pain	Eye disorders	Placebo	4	94
other	Eye pain	Eye disorders	Low Concentration	2	96
other	Eye pain	Eye disorders	High Concentration	6	96
other	Nasopharyngitis	Infections and infestations	Placebo	10	94
other	Nasopharyngitis	Infections and infestations	Low Concentration	5	96
other	Nasopharyngitis	Infections and infestations	High Concentration	9	96
serious	Lung adenocarcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Placebo	0	94
serious	Lung adenocarcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Low Concentration	0	96
serious	Lung adenocarcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	High Concentration	1	96

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01189032/events